cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
10x Genomics Inc
16 own
14 watching
Current Price
$0
$0.33
(0.61%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
6,310.54M
52-Week High
52-Week High
58.2984
52-Week Low
52-Week Low
23.81
Average Volume
Average Volume
0.05M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization6,310.54M
icon52-Week High58.2984
icon52-Week Low23.81
iconAverage Volume0.05M
iconDividend Yield--
iconP/E Ratio--
What does the 10x Genomics Inc do?
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems. It offers chromium instruments, enzymes, reagents, microfluidic chips, and other consumable products, as well as software for analyzing biological systems. The company serves researchers in approximately 40 countries. Its customers include a range of academic, government, biopharmaceutical, biotechnology, and other institutions worldwide. 10X Genomics, Inc. was formerly known as 10X Technologies, Inc. and changed its name to 10X Genomics, Inc. in November 2014. The company was incorporated in 2012 and is based in Pleasanton, California.
Read More
How much money does 10x Genomics Inc make?
News & Events about 10x Genomics Inc.
Ticker Report
1month ago
10x Genomics, Inc. (NASDAQ:TXG Get Rating) CEO Serge Saxonov sold 2,000 shares of the stock in a transaction on Friday, April 14th. The shares were sold at an average price of $53.82, for a total value of $107,640.00. Following the completion of the transaction, the chief executive officer ...
Zolmax
1month ago
10x Genomics, Inc. (NASDAQ:TXG Get Rating) CEO Serge Saxonov sold 2,000 shares of 10x Genomics stock in a transaction on Friday, April 14th. The shares were sold at an average price of $53.82, for a total value of $107,640.00. Following the completion of the transaction, the chief executive officer ...
Zolmax
4 months ago
Shares of 10x Genomics, Inc. (NASDAQ:TXG Get Rating) have earned a consensus recommendation of Hold from the eleven analysts that are currently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and four ...
Ticker Report
8 months ago
Brinker Capital Investments LLC bought a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG Get Rating) during the second quarter, according to the company in its most recent disclosure with the Securities Exchange Commission. The fund bought 9,262 shares of the companys ...
TheStreet.com - Investing
8 months ago
Twist Bioscience, 10x Genomics, and others with large international exposure could be squeezed by global currency selloffs.Twist Bioscience, 10x Genomics, and others with large international exposure could be squeezed by global currency selloffs.Biotech investors have no shortage of troubles at the ...
Frequently Asked Questions
Frequently Asked Questions
What is 10x Genomics Inc share price today?
plus_minus_icon
Can Indians buy 10x Genomics Inc shares?
plus_minus_icon
How can I buy 10x Genomics Inc shares from India?
plus_minus_icon
Can Fractional shares of 10x Genomics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in 10x Genomics Inc stocks?
plus_minus_icon
What is today’s traded volume of 10x Genomics Inc?
plus_minus_icon
What is today’s market capitalisation of 10x Genomics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of 10x Genomics Inc?
plus_minus_icon
What percentage is 10x Genomics Inc down from its 52-Week High?
plus_minus_icon
What percentage is 10x Genomics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.33
(0.61%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00